Shruti Gupta, MD, MPH, and David Leaf, MD, MMSc, of the Renal Division, Department of Medicine at Brigham and Women's ...

Often seen as an option of last resort for ventricular tachycardia, new research suggests catheter ablation could have a ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

National Prescription Drug Take Back Day is April 26, and you can drop off unwanted prescription drugs at participating law ...

Toripalimab is an anti-PD-1 monoclonal antibody developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, and to induce PD-1 receptor internalization (endocytosis ...

Asurvey by the Public Policy Institute of Californiafound that Kern County has filed more Proposition 36 cases per capita ...

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its BTK inhibitor orelabrutinib received approval from the China National Medical Products ...

An HSS official told USA TODAY that the department is not creating an autism registry, but is pursuing the real-world data ...

Investors will focus on lead drug Cabometyx’s performance when Exelixis EXEL reports first-quarter 2025 results shortly. The ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...